ArticleFrontiers in medicine2025

The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study.

Satoko Sasatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.